glp-1 signaling pathway GLP-1R and Functional Molecules in Incretin Therapy GLP-1R and Diabetes

Front Endocrinol 10:389 Godinho R, Mega C, Teixeira-de-Lemos E, Carvalho E, Teixeira F, Fernandes R, Reis F (2015) The Place of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Therapeutics: A Me Too or the Special One Antidiabetic Class

doi: 10.18632/oncotarget.v9i51 96 ManasanchEEOrlowskiRZ

Key Takeaways: Section 7 PSAOs provide independent pharmacies collective contracting scale but cannot replicate the negotiating leverage of chain pharmacies, resulting in persistent 8-12% reimbursement differentials

Compared to CJC-1295 without DAC (Mod GRF 1-29, tetra-substituted GHRH 1-29 analog without albumin, 30-minute half-life), Tesamorelin covers the complete 1-44 sequence of native GHRH with N-terminal protective group

Despite the limited number of patients, this study shows that a multimodal combined antioxidant treatment can yield good outcomes